Cargando…
Dopamine D1 receptor-mediated activation of the ERK signaling pathway is involved in the osteogenic differentiation of bone mesenchymal stem cells
BACKGROUND: Osteogenic differentiation of bone mesenchymal stem cells (BMSCs) is regulated by numerous signaling pathways. Dopamine (DA), a neurotransmitter, has previously been demonstrated to induce new bone formation by stimulating the receptors on BMSCs, but the essential mediators of DA-induced...
Autores principales: | Wang, Chen-Xi, Ge, Xi-Yuan, Wang, Ming-Yue, Ma, Ting, Zhang, Yu, Lin, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942280/ https://www.ncbi.nlm.nih.gov/pubmed/31900224 http://dx.doi.org/10.1186/s13287-019-1529-x |
Ejemplares similares
-
Titanium discs coated with 3,4-dihydroxy-l-phenylalanine promote osteogenic differentiation of human bone mesenchymal stem cells in vitro
por: Ma, Ting, et al.
Publicado: (2019) -
Naringin enhances osteogenic differentiation through the activation of ERK signaling in human bone marrow mesenchymal stem cells
por: Wang, Huichao, et al.
Publicado: (2017) -
Human Amnion-Derived Mesenchymal Stem Cells Promote Osteogenic Differentiation in Human Bone Marrow Mesenchymal Stem Cells by Influencing the ERK1/2 Signaling Pathway
por: Wang, Yuli, et al.
Publicado: (2016) -
Effect of porous tantalum on promoting the osteogenic differentiation of bone marrow mesenchymal stem cells in vitro through the MAPK/ERK signal pathway
por: Dou, Xiaojie, et al.
Publicado: (2019) -
Activation of dopamine receptor D1 promotes osteogenic differentiation and reduces glucocorticoid-induced bone loss by upregulating the ERK1/2 signaling pathway
por: Zhu, Jie, et al.
Publicado: (2022)